Stockholders' Equity (Tables)

9 Months Ended

Sep. 30, 2022

Stockholders' Equity

Summary of the stock option activity

		Weighted		Weighted
		Average		Average	Aggregate
	Number of	Exercise		Remaining	Intrinsic
	Shares	Price		Term	Value
Balance as of December 31, 2021	4,560	$	6.29	3.07	$	2,670
Granted	714		3.88
Exercised	(308)		1.02
Forfeited	(250)		6.33
Expired	(512)		7.48
Balance as of September 30, 2022	4,204		6.12	3.58		178
Expected to vest at September 30, 2022	4,204		6.12	3.56		178
Exercisable at September 30, 2022	3,315		6.23	2.09		178

Summary of the restricted stock unit activity

		Weighted Average Grant-
	Shares	Date Fair Value
Outstanding as of December 31, 2021	5,235	$	8.88
Granted	8,104		3.12
Vested	(4,179)		8.32
Forfeited	(904)		6.24
Outstanding as of September 30, 2022	8,256	$	3.81

Summary of Stock-Based Compensation Expense

	Three Months Ended September 30,				Nine Months Ended September 30,
	2022		2021		2022		2021
Cost of revenue, excluding depreciation and amortization	$	460	$	388	$	3,615	$	543
Sales and marketing		550		37		2,663		98
General and administrative		2,448		59		8,828		160
Research and development		177		19		3,753		49
Total	$	3,635	$	503	$	18,859	$	850